Head-to-Head Comparison: Clinical Evidence & Real-World Use
Does Wegovy Work for Everyone: Understanding Individual Response Patterns
The question "does Wegovy work for everyone" reflects a crucial understanding that weight management treatments don't produce identical results across all patients. Clinical evidence from the STEP trials demonstrates that whilst average weight loss was approximately 15% at 68 weeks, individual responses ranged significantly. Some participants achieved greater than 20% weight reduction, whilst others experienced more modest results of 5-10%.
When comparing Wegovy vs Mounjaro for universal effectiveness, both treatments show similar variability in individual responses. Wegovy's semaglutide targets GLP-1 receptors exclusively, whilst Mounjaro's tirzepatide activates both GIP and GLP-1 pathways. This dual mechanism may explain why some patients who don't respond optimally to Wegovy find better results with Mounjaro, and vice versa. Your prescriber can help determine which mechanism aligns better with your metabolic profile.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
Understanding the cost implications helps answer whether Wegovy works for everyone from a practical standpoint. Wegovy pricing at EverydayMeds ranges from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) cost £169.99, providing your first two months of treatment. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Mounjaro follows a similar pricing structure but with different dose intervals, starting at 2.5mg and escalating to 15mg maximum. Both treatments require identical clinical assessments and prescriber reviews through our GPhC-registered pharmacy (#9012878). The question of whether Wegovy works for everyone often comes down to finding the right dose and treatment duration, which applies equally to both medications.
Clinical Evidence: Does Wegovy Work for Everyone According to STEP Trials
The STEP trial programme provides the most comprehensive answer to "does Wegovy work for everyone." In STEP 1, conducted by Wilding et al. and published in NEJM 2021, patients taking Wegovy alongside a reduced-calorie diet and increased physical activity achieved approximately 15% average weight loss at 68 weeks versus 2.4% with placebo. However, the trial data shows significant individual variation in response rates.
STEP 5 data demonstrates that weight loss of approximately 15.2% was sustained at 2 years, suggesting that Wegovy works for the majority of patients who complete the full treatment protocol. The SELECT trial further showed a 20% reduction in major cardiovascular events, indicating benefits beyond weight management for many patients.
How Wegovy Works: GLP-1 Mechanism and Individual Variation
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. When you inject Wegovy weekly using the FlexTouch pen, it activates GLP-1 receptors in your brain's appetite centres, reducing hunger signals and promoting satiety after smaller meals. The medication also slows gastric emptying, keeping food in your stomach longer and extending the feeling of fullness. Individual genetic variations in GLP-1 receptor sensitivity may explain why Wegovy doesn't work identically for everyone. Some patients experience pronounced appetite suppression within the first few weeks, whilst others require the full dose escalation to 2.4mg before noticing significant effects.
EverydayMeds Ordering Process: Access to Both Treatments
Our streamlined process makes it simple to access either Wegovy or Mounjaro based on your clinical needs. Complete our 3-minute online clinical assessment, providing detailed medical history and current medications to help prescribers determine suitability. Standard prescriber review takes 3 working days, with express 24-hour review available for urgent cases. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all treatments meet MHRA standards and include comprehensive patient information leaflets. This identical process applies whether you're prescribed Wegovy or Mounjaro, ensuring consistent clinical oversight.
Storage and Practical Considerations: Wegovy vs Mounjaro
Practical factors significantly influence whether Wegovy works for everyone in real-world settings. Wegovy requires refrigerated storage at 2-8°C but can remain at room temperature below 30°C for up to 6 weeks once removed from the fridge. This extended room temperature stability makes Wegovy more convenient for travel and reduces wastage from accidental temperature exposure. Mounjaro only tolerates 21 days at room temperature, requiring more careful storage management. The FlexTouch pen system used by Wegovy provides dose accuracy and ease of injection, with clear dose escalation from 0.25mg through 0.5mg, 1mg, 1.7mg, to 2.4mg maintenance dosing. Dose escalation cannot be skipped and is essential for minimising gastrointestinal side effects whilst optimising efficacy.
Individual Response Factors: Why Wegovy Works Differently for Everyone
Multiple factors influence whether Wegovy works optimally for individual patients, explaining the variation in clinical outcomes. Baseline BMI, insulin resistance severity, genetic polymorphisms in GLP-1 receptor expression, and concurrent medications all affect treatment response. Patients with higher baseline BMI often see greater absolute weight loss, whilst those with metabolic syndrome may require longer treatment duration to achieve optimal results.
Lifestyle adherence significantly impacts whether Wegovy works for everyone, as the medication must be combined with a reduced-calorie diet and increased physical activity. Patients who implement comprehensive dietary changes and regular exercise typically achieve superior outcomes compared to those relying solely on medication effects. Age, gender, and previous weight loss attempts also influence individual response patterns, highlighting why personalised prescriber assessment is essential.
Making Your Choice: Wegovy vs Mounjaro Clinical Decision
The decision between Wegovy and Mounjaro often resolves the question "does Wegovy work for everyone" by providing an alternative mechanism when single GLP-1 activation proves insufficient. Our clinical team evaluates factors including diabetes status, cardiovascular risk, gastrointestinal tolerance, and previous weight management attempts to guide treatment selection. Both medications require identical monitoring protocols and lifestyle modifications to achieve optimal results. EverydayMeds' unique position offering both treatments means you can switch between options under prescriber guidance without changing pharmacies, ensuring continuity of care and consistent pricing. Whether Wegovy works for you specifically depends on your individual clinical profile, which our assessment process is designed to evaluate comprehensively.
Ready to discover whether Wegovy or Mounjaro is right for your weight management goals? Start your clinical assessment today and benefit from our expert prescriber guidance in choosing between these evidence-based treatments. New customers save with code FIRST40, whilst returning customers use DOSE25 at checkout. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine, properly stored medication with next-day delivery once approved. Don't let uncertainty about individual effectiveness delay your weight management journey – our clinical team provides the personalised assessment needed to optimise your treatment choice.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
